Repeated CD45RA‐depleted DLI successfully increases donor chimerism in a patient with beta‐thalassemia major after haploidentical stem cell transplant-Reference-Cited by-同舟云学术

Repeated CD45RA‐depleted DLI successfully increases donor chimerism in a patient with beta‐thalassemia major after haploidentical stem cell transplant

Published:2020-12-12 Issue:5 Volume:25 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Chan Wilson Y. K.¹^ORCID,Kwok Janette S. Y.²,Chiang Alan K. S.¹,Chan Godfrey C. F.¹,Lee Pamela P. W.¹,Ha Shau‐Yin¹,Cheuk Daniel K. L.¹

Affiliation:

1. Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong and Queen Mary Hospital Hong Kong China

2. Division of Transplantation and Immunogenetics Department of Pathology Queen Mary Hospital Hong Kong China

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13945

Reference28 articles.

1. Outcomes of Transplantation with Related- and Unrelated-Donor Stem Cells in Children with Severe Thalassemia

2. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation

3. The cure of thalassemia by bone marrow transplantation

4. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction

5. Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of High-Dose Memory CD45RO+ Donor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell Transplantation;Cytotherapy;2024-07

2. Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease;Frontiers in Immunology;2023-02-16

3. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions;The Lancet Haematology;2022-12

4. CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation;Frontiers in Immunology;2022-08-08

5. Successful haploidentical hematopoietic stem cell transplantation (HSCT) and durable engraftment by repeated donor lymphocyte infusions for a Chinese patient with transfusion‐dependent hemoglobin (Hb) Hammersmith and massive splenomegaly;Pediatric Transplantation;2022-04-09